Related references
Note: Only part of the references are listed.GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus
C. P. Chung et al.
LUPUS (2016)
GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study
Margery A. Connelly et al.
CLINICA CHIMICA ACTA (2016)
Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus
Akintunde O. Akinkuolie et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation
James D. Otvos et al.
CLINICAL CHEMISTRY (2015)
Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
Michelle J. Ormseth et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
Iain B. McInnes et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function
Eke G. Gruppen et al.
PLOS ONE (2015)
GLYCA, A NOVEL BIOMARKER OF SYSTEMIC INFLAMMATION, IMPROVES CARDIOVASCULAR RISK PREDICTION IN A HIGH-RISK CORONARY CATHETERIZATION COHORT
Robert McGarrah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Glycans in immune recognition and response
Ron Amon et al.
CARBOHYDRATE RESEARCH (2014)
Lipoprotein Particle Concentrations in Children and Adults following Kawasaki Disease
Jonathan Lin et al.
JOURNAL OF PEDIATRICS (2014)
A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events
Akintunde O. Akinkuolie et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan
Shohei Ogata et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Treatment Response in Kawasaki Disease Is Associated with Sialylation Levels of Endogenous but Not Therapeutic Intravenous Immunoglobulin G
Shohei Ogata et al.
PLOS ONE (2013)
Inflammation modulates human HDL composition and function in vivo
Margarita de la Llera Moya et al.
ATHEROSCLEROSIS (2012)
Function and 3D Structure of the N-Glycans on Glycoproteins
Masamichi Nagae et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Lipoprotein Subclasses Determined by Nuclear Magnetic Resonance Spectroscopy and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis
Cecilia P. Chung et al.
JOURNAL OF RHEUMATOLOGY (2010)
High-density lipoprotein and the acute phase response
Anisa Jahangiri
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Phospholipase A2-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH
Katariina Lahdesmaki et al.
ATHEROSCLEROSIS (2009)
When Children With Kawasaki Disease Grow Up Myocardial and Vascular Complications in Adulthood
John B. Gordon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
The truth about quality: medical usefulness and analytical reliability of laboratory tests
JO Westgard et al.
CLINICA CHIMICA ACTA (2004)
Test result variation and the quality of evidence-based clinical guidelines
CG Fraser
CLINICA CHIMICA ACTA (2004)
Diagnosis, treatment, and long-term management of Kawasaki disease - A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association
JW Newburger et al.
CIRCULATION (2004)
Share Paper
